ATE142499T1 - Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren - Google Patents

Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren

Info

Publication number: ATE142499T1
Authority: AT; Austria
Prior art keywords: acid; phosphoenolpyrugenic; creatine phosphate; treat tumors; tumors
Prior art date: 1991-12-03

Application number

AT93901806T

Other languages

English (en)

Inventor

Nicole Bru

Victor Izrael

Original Assignee

Nicole Bru

Victor Izrael

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-03

Filing date

1992-12-01

Publication date

1996-09-15

1992-12-01 Application filed by Nicole Bru, Victor Izrael filed Critical Nicole Bru

1996-09-15 Application granted granted Critical

1996-09-15 Publication of ATE142499T1 publication Critical patent/ATE142499T1/de

Links

DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 title abstract 4
206010028980 Neoplasm Diseases 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
238000000034 method Methods 0.000 abstract 2
DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 abstract 2
238000002512 chemotherapy Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT93901806T 1991-12-03 1992-12-01 Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren ATE142499T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9114967A FR2684381B1 (fr)	1991-12-03	1991-12-03	Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active.

Publications (1)

Publication Number	Publication Date
ATE142499T1 true ATE142499T1 (de)	1996-09-15

Family

ID=9419629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93901806T ATE142499T1 (de)	1991-12-03	1992-12-01	Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren

Country Status (21)

Country	Link
US (1)	US5219846A (de)
EP (1)	EP0614366B1 (de)
JP (1)	JP3437574B2 (de)
KR (1)	KR100235893B1 (de)
AT (1)	ATE142499T1 (de)
AU (1)	AU3260093A (de)
BG (1)	BG61595B1 (de)
CA (1)	CA2124793C (de)
CZ (1)	CZ284966B6 (de)
DE (1)	DE69213757T2 (de)
DK (1)	DK0614366T3 (de)
ES (1)	ES2094522T3 (de)
FR (1)	FR2684381B1 (de)
GR (1)	GR3021876T3 (de)
HU (1)	HU216826B (de)
LV (1)	LV11821B (de)
RO (1)	RO115784B1 (de)
RU (1)	RU2097040C1 (de)
SK (1)	SK280785B6 (de)
UA (1)	UA41285C2 (de)
WO (1)	WO1993010792A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6097994A (en) *	1993-01-27	1994-08-15	Amira, Inc.	Creatine phosphate, creatine phosphate analogs, and uses therefor
AU6165894A (en) *	1993-01-28	1994-08-15	Trustees Of The University Of Pennsylvania, The	Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
US5714361A (en) *	1994-02-14	1998-02-03	Indiana University Foundation	Phosphatase/phosphodiesterase enzyme inhibitors and methods
US5627172A (en) *	1994-03-04	1997-05-06	Natural Supplement Association, Incorporated	Method for reduction of serum blood lipids or lipoprotein fraction
DE19537494C2 (de) *	1995-09-25	1997-10-02	Desitin Arzneimittel Gmbh	Kreatin zum Schutz von neuralem Gewebe
DE19653225A1 (de) *	1996-12-20	1998-06-25	Sueddeutsche Kalkstickstoff	Kreatin-pyruvate und Verfahren zu deren Herstellung
DE10116589A1 (de) *	2001-04-03	2002-10-10	Wulf Droege	Anwendung von Kreatin zur Minderung von oxidativem Stress
RU2309747C2 (ru) *	2002-09-18	2007-11-10	Михаил Владимирович Кутушов	Применение 2-хлорэтилфосфоновой кислоты и ее солей в качестве противоопухолевого средства
AU2004238289A1 (en) *	2003-05-09	2004-11-25	The Trustees Of The University Of Pennsylvania	Compositions and methods for treating cancer
RU2354645C1 (ru) *	2007-11-21	2009-05-10	Закрытое Акционерное Общество "Вертекс"	Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
WO2010074591A1 (ru)	2008-12-24	2010-07-01	Закрытое Акционерное Общество "Beptekc"	Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
RU2428414C2 (ru)	2009-11-03	2011-09-10	Закрытое Акционерное Общество "Вертекс"	Способ получения амидов креатина
WO2016007622A1 (en) *	2014-07-09	2016-01-14	Sidra Medical and Research Center	Imaging of creatine kinase enzyme expression in cancerous tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8200252L (sv) *	1982-01-18	1983-07-19	Pharmacia Ab	Farmaceutisk komposition
IT1214598B (it) *	1985-04-17	1990-01-18	Schiapparelli Farma	Uso terapeutico della fosfocreatina.
IT1191639B (it) *	1985-11-11	1988-03-23	Schiapparelli Farma	Composizione farmaceutica contenente fosfocreatina e metodo per preparla
US4874882A (en) *	1986-03-25	1989-10-17	Ube Industries, Ltd.	Process for preparing monosodium phosphoenolpyruvate
US4769318A (en) *	1986-06-03	1988-09-06	Ube Industries, Ltd.	Additive solution for blood preservation and activation

1991
- 1991-12-03 FR FR9114967A patent/FR2684381B1/fr not_active Expired - Lifetime
- 1991-12-20 US US07/811,058 patent/US5219846A/en not_active Expired - Lifetime
1992
- 1992-12-01 JP JP50989193A patent/JP3437574B2/ja not_active Expired - Fee Related
- 1992-12-01 AU AU32600/93A patent/AU3260093A/en not_active Abandoned
- 1992-12-01 AT AT93901806T patent/ATE142499T1/de active
- 1992-12-01 CZ CZ941343A patent/CZ284966B6/cs not_active IP Right Cessation
- 1992-12-01 UA UA94005324A patent/UA41285C2/uk unknown
- 1992-12-01 RO RO94-00930A patent/RO115784B1/ro unknown
- 1992-12-01 KR KR1019940701870A patent/KR100235893B1/ko not_active Expired - Fee Related
- 1992-12-01 DE DE69213757T patent/DE69213757T2/de not_active Expired - Lifetime
- 1992-12-01 WO PCT/FR1992/001118 patent/WO1993010792A1/fr not_active Ceased
- 1992-12-01 ES ES93901806T patent/ES2094522T3/es not_active Expired - Lifetime
- 1992-12-01 SK SK683-94A patent/SK280785B6/sk not_active IP Right Cessation
- 1992-12-01 DK DK93901806.5T patent/DK0614366T3/da active
- 1992-12-01 CA CA002124793A patent/CA2124793C/en not_active Expired - Fee Related
- 1992-12-01 EP EP93901806A patent/EP0614366B1/de not_active Expired - Lifetime
- 1992-12-01 HU HU9401656A patent/HU216826B/hu not_active IP Right Cessation
- 1992-12-01 RU RU9294030808A patent/RU2097040C1/ru not_active IP Right Cessation
1994
- 1994-06-01 BG BG98825A patent/BG61595B1/bg unknown
1996
- 1996-12-04 GR GR960403287T patent/GR3021876T3/el unknown
1997
- 1997-02-05 LV LVP-97-18A patent/LV11821B/lv unknown

Also Published As

Publication number	Publication date
BG61595B1 (bg)	1998-01-30
RU94030808A (ru)	1996-10-20
DE69213757D1 (de)	1996-10-17
CZ284966B6 (cs)	1999-04-14
RO115784B1 (ro)	2000-06-30
DK0614366T3 (da)	1996-11-25
JP3437574B2 (ja)	2003-08-18
FR2684381B1 (fr)	1995-05-05
HU9401656D0 (en)	1994-09-28
CA2124793C (en)	2005-09-20
BG98825A (bg)	1995-05-31
CZ134394A3 (en)	1994-12-15
DE69213757T2 (de)	1997-04-03
WO1993010792A1 (fr)	1993-06-10
EP0614366A1 (de)	1994-09-14
UA41285C2 (uk)	2001-09-17
GR3021876T3 (en)	1997-03-31
HU216826B (hu)	1999-09-28
FR2684381A1 (fr)	1993-06-04
LV11821B (en)	1997-12-20
ES2094522T3 (es)	1997-01-16
SK68394A3 (en)	1995-03-08
US5219846A (en)	1993-06-15
SK280785B6 (sk)	2000-07-11
KR100235893B1 (ko)	1999-12-15
AU3260093A (en)	1993-06-28
HUT68876A (en)	1995-08-28
RU2097040C1 (ru)	1997-11-27
EP0614366B1 (de)	1996-09-11
JPH07501534A (ja)	1995-02-16
LV11821A (lv)	1997-08-20
CA2124793A1 (en)	1993-06-10

Similar Documents

Publication	Publication Date	Title
DE3687069D1 (de)	1992-12-10	Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
ATE71629T1 (de)	1992-02-15	Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
ATE142499T1 (de)	1996-09-15	Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren
DE3683318D1 (de)	1992-02-20	Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
DE69737689D1 (de)	2007-06-14	Verwendung von pyridazinone oder phosphinoxid verbindungen zur behandlung der herzarrhythmie
DE3788057D1 (de)	1993-12-09	Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
ATE484294T1 (de)	2010-10-15	Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69110779D1 (de)	1995-08-03	Schilddrüsenhormone zur kardialen behandlung.
ATE73995T1 (de)	1992-04-15	Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.
DE58907851D1 (de)	1994-07-14	Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE69331833D1 (de)	2002-05-23	Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose
ATE192923T1 (de)	2000-06-15	Verwendung von boswelliasäure zur behandlung von hirntumoren
ATE251631T1 (de)	2003-10-15	Dipohosphonsäuresalze für die behandlung von osteoporose
DE59902666D1 (de)	2002-10-17	Edelfosin zur behandlung von hirntumoren
DE3856329D1 (de)	1999-06-10	Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE25969T1 (de)	1987-04-15	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
EP1056458A4 (de)	2001-06-20	Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE3577550D1 (de)	1990-06-13	Aminocarbonsaeurekomplexe zur behandlung von knochentumoren.
DE3686688D1 (de)	1992-10-15	Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten.
ES2156011T3 (es)	2001-06-01	Derivados de ciclopeptidos.
ATE126437T1 (de)	1995-09-15	Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DK664188D0 (da)	1988-11-29	Butylhydroxyanisoler til behandling af retrovirale sygdomme
DE69214647D1 (de)	1996-11-21	Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz